Biomarkers: Validation and Verification

The biomarker validation study represents a key step for the translation of the bench findings into clinical practice for tailored prescription or to accelerate the development of new drugs and other medical products. Biomarker validation is a multifaceted procedure that requires collaboration of multiple clinical centers and carries a significant financial burden and for which robust quantitative assays have been developed will enter the validation phase.

  • Biomarker validation
  • Biomarker identification

Related Conference of Biomarkers: Validation and Verification

June 05-06, 2023

6th Euro Oncology and Cancer Summit

Valencia, Spain
June 05-06, 2023

8th World Conference on Breast and Cervical Cancer

Valencia, Spain
June 12-13, 2023

13th World Congress on Breast Cancer Research & Therapies

Melbourne, Australia
June 19-20, 2023

11th World Summit on Cancer Science and Oncology

Vienna, Austria
July 19-20, 2023

42nd World Cancer Conference

Zurich, Switzerland
July 24-25, 2023

10th World Congress on Epigenetics and Chromosome

Amsterdam, Netherlands
July 27-28, 2023

6th International Conference on Women Oncology

Vancouver, Canada
August 07-08, 2023

4th World Congress on Breast Cancer

Paris, France
August 23-24, 2023

23rd World Congress on Cancer and Diagnostics

Toronto, Canada
September 07-08, 2023

7th Global Meeting on Oncology and Radiology

Paris, France
September 21-22, 2023

15th Annual Conference on Cancer Research

Kualalumpur, Malaysia
October 04-05, 2023

8th Global Summit on Cancer Science and Oncology

Barcelona, Spain
November 08-09, 2023

International Conference on Cancer Biology and Therapeutics

Budapest, Hungary
November 15-16, 2023

36th Conference on Preventive Oncology and Diagnostic Cancer

Edinburgh, Scotland

Biomarkers: Validation and Verification Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in